JP2019503179A5 - - Google Patents

Download PDF

Info

Publication number
JP2019503179A5
JP2019503179A5 JP2018536777A JP2018536777A JP2019503179A5 JP 2019503179 A5 JP2019503179 A5 JP 2019503179A5 JP 2018536777 A JP2018536777 A JP 2018536777A JP 2018536777 A JP2018536777 A JP 2018536777A JP 2019503179 A5 JP2019503179 A5 JP 2019503179A5
Authority
JP
Japan
Prior art keywords
sequence
protein
cells
expression
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018536777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019503179A (ja
JP6937309B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/015130 external-priority patent/WO2017132376A1/en
Publication of JP2019503179A publication Critical patent/JP2019503179A/ja
Publication of JP2019503179A5 publication Critical patent/JP2019503179A5/ja
Application granted granted Critical
Publication of JP6937309B2 publication Critical patent/JP6937309B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018536777A 2016-01-27 2017-01-26 ハイブリッドプロモーターおよびその使用 Active JP6937309B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662388391P 2016-01-27 2016-01-27
US62/388,391 2016-01-27
PCT/US2017/015130 WO2017132376A1 (en) 2016-01-27 2017-01-26 Hybrid promoter and uses thereof

Publications (3)

Publication Number Publication Date
JP2019503179A JP2019503179A (ja) 2019-02-07
JP2019503179A5 true JP2019503179A5 (enExample) 2021-04-22
JP6937309B2 JP6937309B2 (ja) 2021-09-22

Family

ID=58044162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536777A Active JP6937309B2 (ja) 2016-01-27 2017-01-26 ハイブリッドプロモーターおよびその使用

Country Status (5)

Country Link
US (1) US11028410B2 (enExample)
EP (1) EP3408397B1 (enExample)
JP (1) JP6937309B2 (enExample)
ES (1) ES2823173T3 (enExample)
WO (1) WO2017132376A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11098310B2 (en) * 2016-01-27 2021-08-24 Just-Evotec Biologics, Inc. Expression from transposon-based vectors and uses
US20240035037A1 (en) * 2016-01-27 2024-02-01 Just-Evotec Biologics, Inc. Transposon-based vectors and uses
US12421524B2 (en) * 2018-09-24 2025-09-23 Merck Sharp & Dohme Llc Expression vectors for eukaryotic expression systems
PT115073A (pt) 2018-10-09 2020-05-29 Inst De Biologia Molecular E Celular Ibmc Ácido nucleico para ativar a expressão e a produção de proteínas
KR102937659B1 (ko) 2020-02-19 2026-03-10 우시 바이올로직스 아일랜드 리미티드 강화된 발현 시스템 및 그 사용방법
WO2022204067A1 (en) * 2021-03-24 2022-09-29 Dna Twopointo Inc. Tetracycline-inducible expression systems
CA3266599A1 (en) 2022-09-07 2024-11-07 Quantitative Biosciences, Inc. UNIQUE VARIABLE DOMAIN ANTIBODIES SPECIFIC TO FENTANYL AND USE IN A CONTINUOUS AGGLUTINATION TEST
CN122349567A (zh) 2023-12-11 2026-07-07 济世易为生物有限公司 利用反式剪接和拆分型选择标记的蛋白质表达
EP4711442A1 (en) 2024-09-15 2026-03-18 Quantitative Biosciences, Inc. Microfluidic chip for the parallel culture of microbial biosensor strains

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30985A (en) 1860-12-18 Thomas l
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
CA1341482C (en) 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
EP0281604B1 (en) 1986-09-02 1993-03-31 Enzon Labs Inc. Single polypeptide chain binding molecules
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
ATE135045T1 (de) 1988-07-23 1996-03-15 Delta Biotechnology Ltd Sekretorische leader-sequenzen
WO1990003430A1 (en) 1988-09-23 1990-04-05 Cetus Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
DE69233528T2 (de) 1991-11-25 2006-03-16 Enzon, Inc. Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
US5972650A (en) 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch
US6022952A (en) 1998-04-01 2000-02-08 University Of Alberta Compositions and methods for protein secretion
US6210924B1 (en) 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
JP4475814B2 (ja) 1998-11-20 2010-06-09 扶桑薬品工業株式会社 タンパク質発現ベクターとその使用
CA2368068A1 (en) 1999-03-18 2000-09-21 Steven M. Ruben 27 human secreted proteins
US20050005310A1 (en) 1999-07-12 2005-01-06 Genentech, Inc. Expression vectors and methods
GB2355459B (en) 1999-11-29 2001-09-26 Isis Innovation A dominant conditional lethal genetic system
DK1332222T3 (da) 2000-11-03 2009-07-06 Genentech Inc Stofskifteændringer i fermenteringer der udtrykker rekombinante proteiner
US20050019925A1 (en) 2002-11-14 2005-01-27 Genentech, Inc. Intron fusion construct and method of using for selecting high-expressing production cell lines
ATE399872T1 (de) 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
GB2404382B (en) 2003-07-28 2008-01-30 Oxitec Ltd Pest control
WO2005016130A2 (en) 2003-08-14 2005-02-24 Wyeth Recombinant lubricin molecules and uses thereof
KR20050022071A (ko) 2003-08-26 2005-03-07 삼성에스디아이 주식회사 플라즈마 디스플레이 패널
EP1819812B1 (en) 2004-12-02 2012-05-30 Merck Serono SA The lupac bifunctional marker and its use in protein production
WO2006063292A1 (en) 2004-12-08 2006-06-15 Icos Corporation Recombinant method for making multimeric proteins
CN101405297A (zh) 2006-02-03 2009-04-08 惠氏公司 Lingo-1结构
GB2443186A (en) 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
CA2656598A1 (en) 2006-08-07 2008-02-21 Avigenics, Inc. Hybrid promoters
FR2910490B1 (fr) 2006-12-20 2012-10-26 Lab Francais Du Fractionnement Lignee cellulaire a forte activite transcriptionnelle pour la production de proteines, notamment therapeutiques
KR100884214B1 (ko) 2007-04-04 2009-02-19 주식회사 마크로젠 Ｃａｅｖ-계 벡터 시스템
AU2008271658B8 (en) 2007-06-29 2013-07-04 F. Hoffmann-La Roche Ag Promoter
PT2592148T (pt) 2007-10-12 2018-11-12 Hoffmann La Roche Expressão proteica de múltiplos ácidos nucleicos
WO2009053368A1 (en) 2007-10-22 2009-04-30 Merck Serono S.A. Single ifn-beta fused to a mutated igg fc fragment
SI2796466T1 (en) 2007-12-07 2018-01-31 Zymogenetics, Inc. Molecules of Humanized Specifics Specifiable for IL-31
US8795981B2 (en) 2008-08-08 2014-08-05 Molecular Devices, Llc Cell detection
US9445581B2 (en) 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
GB201004143D0 (en) 2010-03-12 2010-04-28 Isis Innovation Promoter sequence for DNA and viral vectors
RU2661764C2 (ru) 2011-05-27 2018-07-19 Эббви Байотекнолоджи Лтд., Композиции и способы на основе dac hyp
EP2741773A1 (en) 2011-08-08 2014-06-18 AbbVie Biotherapeutics Inc. Methods of treating progressive forms of multiple sclerosis
CA2857298A1 (en) 2011-11-30 2013-06-06 Abbvie Biotherapeutics Inc. Vectors and host cells comprising a modified sv40 promoter for protein expression
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
SG10201700169PA (en) 2011-12-22 2017-02-27 Hoffmann La Roche Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
KR101494072B1 (ko) 2012-03-12 2015-02-17 한화케미칼 주식회사 변이된 글루타민 합성효소 유전자를 포함하는 벡터 및 이를 이용한 목적 단백질의 생산방법
AR091116A1 (es) 2012-05-22 2015-01-14 Bristol Myers Squibb Co Anticuerpos biespecificos y sus metodos de uso
EP2674495A1 (en) 2012-06-14 2013-12-18 Sanofi CHO expression system
EP2711428A1 (en) 2012-09-21 2014-03-26 Lonza Biologics plc. Site-specific integration
SG11201502801RA (en) * 2012-10-10 2015-06-29 Chugai Pharmaceutical Co Ltd Method for establishing modified host cell
US9290552B2 (en) 2012-12-21 2016-03-22 Dna Twopointo, Inc. Fluorescent and colored proteins and methods for using them
CA2904146C (en) 2013-03-08 2023-03-21 Neuclone Biologics Pty Ltd A cell expression system
EP3683314A1 (en) 2013-10-07 2020-07-22 Prestige Biopharma Pte. Ltd. Bicistronic expression vector for antibody expression and method for producing antibody using same
US10927384B2 (en) 2014-04-09 2021-02-23 Dna Twopointo Inc. DNA vectors, transposons and transposases for eukaryotic genome modification
HUE052552T2 (hu) 2014-04-09 2021-05-28 Dna Twopointo Inc Javított nukleinsav-konstrukciók eukarióta génexpresszióhoz
US11280790B2 (en) 2016-10-04 2022-03-22 Svar Life Science Ab System and products for improved quantification of ADCC activity
US12534502B2 (en) 2016-10-04 2026-01-27 Svar Life Science Ab FGF21 responsive reporter gene cell line

Similar Documents

Publication Publication Date Title
JP6937309B2 (ja) ハイブリッドプロモーターおよびその使用
US11685933B2 (en) Inducible expression from transposon-based vectors and uses
US10975151B2 (en) ASPGR antibodies and uses thereof
US11692193B2 (en) Expression from transposon-based vectors and uses
JP7504027B2 (ja) 互いに連結された２つの抗原結合ドメインを含む抗原結合分子
KR102559149B1 (ko) 재조합효소 매개 카세트 교환을 이용한 다중특이적 항체 스크리닝 방법
CN111448314A (zh) 根据可开发性选择真核细胞展示系统中的多肽药物
CN107312796A (zh) 蛋白质的生产方法
JP2018535213A (ja) ＩｇＧ軽鎖におけるＮ末端切断の防止
US20190346456A1 (en) High throughput antibody variant screening method
TW202328184A (zh) 特異性識別fcrn的抗體及其用途
JP2017530718A (ja) 宿主細胞における異種由来遺伝子の発現を改善するためのプロモーター及び調節エレメント
JP2023179537A (ja) 改変されたヒト可変ドメイン
US20240035037A1 (en) Transposon-based vectors and uses
US20190031752A1 (en) Method for Producing Antibodies
TW202321312A (zh) 包含基於ｍｈｃ或ｍｈｃ樣蛋白的異源二聚體的二價雙特異性嵌合抗體
WO2025190332A1 (zh) 特异性结合nkg2a抗原和pd-l1抗原的多特异性抗体及其应用
CN101180316A (zh) 在哺乳动物宿主细胞中高水平表达重组抗体
JP2010536345A (ja) 新規な方法および細胞系
BR112013013354A2 (pt) molécula de ligação ao antígeno capaz de se ligar a uma pluralidade de moléculas de antígeno repetidamente